GCFLU Quadrivalent

GCFLU Quadrivalent is a split-virion, inactivated quadrivalent influenza vaccine developed to provide active immunization against four strains of seasonal influenza virus—two type A (H1N1 and H3N2) and two type B lineages. It is indicated for the prophylaxis of influenza in adults and children from 6 months of age. The vaccine works by stimulating the immune system to produce antibodies against the included viral antigens, thereby providing protection against infection. Clinical studies have demonstrated its safety and immunogenicity across various age groups, with a safety profile comparable to trivalent vaccines[1][3][4][5]. The product has received WHO prequalification for both single-dose and multi-dose presentations[8][9].

Brand names

GCFLU QuadrivalentGC FLU Quadrivalent Multi inj.GC FLU Quadrivalent inj.

Other names

quadrivalent influenza virus vaccine (GC BioPharma)GC FLUquadrivalent inactivated influenza vaccine